Skip to content

D5-PHARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

D5-PHARMA

BE 0479.659.456
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€26,472
2024 · -€65,894+€92,366
Equity
€115,485
2024 · €214,013-€98,528
Cash
€55,962
2024 · €22,604+€33,358
Balance sheet total
€1.5m
2024 · €1.6m-€140,298

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€150,276

    down €150,276 (-19.1%), from €785,694 to €635,418

    of which Other amounts receivable: -€254,695

  • Deferred charges and accrued income +€41,966

    up €41,966 (+118%), from €35,630 to €77,596

  • Tangible fixed assets -€35,502

    down €35,502 (-6.1%), from €582,265 to €546,763

    of which Land and buildings: -€28,001

  • Cash +€33,358

    up €33,358 (+148%), from €22,604 to €55,962

    mainly Receivables within one year (+€150,276) and Depreciation (+€48,736)

  • Stocks and contracts -€18,545

    down €18,545 (-17.3%), from €107,091 to €88,547

Equity and liabilities
  • Profit (loss) carried forward -€98,528

    down €98,528 (-47.8%), from €205,953 to €107,425

  • Debts after one year -€66,837

    down €66,837 (-10.6%), from €632,096 to €565,259

  • Other debts +€25,000

    up €25,000 (+25.0%), from €100,000 to €125,000

Income statement
  • Gross operating margin +€91,313

    up €91,313 (+43.9%), from €207,944 to €299,257

  • Staff costs -€6,714

    down €6,714 (-3.5%), from €192,684 to €185,970

  • Other operating charges +€6,197

    up €6,197 (+211%), from €2,944 to €9,141

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€65,894
Gross operating margin +€91,313
Staff costs +€6,714
Depreciation -€280
Other operating charges -€6,197
Financial income -€54
Financial charges +€870
Result 2025 €26,472
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€224,420
Investment -€1,934
Financing -€189,128
Cash 2024 €22,604
Net result for the year +€26,472
Depreciation +€48,736
Stocks and contracts +€18,545
Receivables within one year +€150,276
Deferred charges and accrued income -€41,966
Trade debts +€13,194
Tax, wage and social debts -€15,835
Other debts +€25,000
Investment in fixed assets (net) -€1,934
Debts after one year -€66,837
Current portion of long-term debt +€2,709
Contributions, distributions and other -€125,000
Cash 2025 €55,962
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,626,470 €1,486,172 -€140,298 -8.6%
Fixed assets 21/28 €675,452 €628,649 -€46,802 -6.9%
Intangible fixed assets 21 €93,186 €81,886 -€11,300 -12.1%
Tangible fixed assets 22/27 €582,265 €546,763 -€35,502 -6.1%
Land and buildings 22 €514,911 €486,910 -€28,001 -5.4%
Plant, machinery and equipment 23 €65,527 €57,437 -€8,090 -12.3%
Furniture and vehicles 24 - €1,718 +€1,718
Other tangible fixed assets 26 €1,828 €699 -€1,129 -61.8%
Current assets 29/58 €951,019 €857,523 -€93,496 -9.8%
Stocks and contracts in progress 3 €107,091 €88,547 -€18,545 -17.3%
Stocks 30/36 €107,091 €88,547 -€18,545 -17.3%
Amounts receivable within one year 40/41 €785,694 €635,418 -€150,276 -19.1%
Trade receivables 40 €85,987 €190,406 +€104,419 +121%
Other amounts receivable 41 €699,706 €445,012 -€254,695 -36.4%
Cash at bank and in hand 54/58 €22,604 €55,962 +€33,358 +148%
Deferred charges and accrued income 490/1 €35,630 €77,596 +€41,966 +118%
Total equity and liabilities 10/49 €1,626,470 €1,486,172 -€140,298 -8.6%
Equity 10/15 €214,013 €115,485 -€98,528 -46.0%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Distributable reserves 133 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 €205,953 €107,425 -€98,528 -47.8%
Amounts payable 17/49 €1,412,457 €1,370,687 -€41,770 -3.0%
Amounts payable after more than one year 17 €632,096 €565,259 -€66,837 -10.6%
Financial debts 170/4 €632,096 €565,259 -€66,837 -10.6%
Amounts payable within one year 42/48 €780,361 €805,428 +€25,067 +3.2%
Current portion of amounts payable after more than one year 42 €64,128 €66,837 +€2,709 +4.2%
Trade debts 44 €575,288 €588,481 +€13,194 +2.3%
Suppliers 440/4 €575,288 €588,481 +€13,194 +2.3%
Taxes, remuneration and social security 45 €40,945 €25,110 -€15,835 -38.7%
Taxes 450/3 €5,009 €0 -€5,009 -100%
Remuneration and social security 454/9 €35,936 €25,110 -€10,826 -30.1%
Other amounts payable 47/48 €100,000 €125,000 +€25,000 +25.0%
Remuneration, social security and pensions 62 €192,684 €185,970 -€6,714 -3.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €48,456 €48,736 +€280 +0.6%
Other operating charges 640/8 €2,944 €9,141 +€6,197 +211%
Gross operating margin 9900 €207,944 €299,257 +€91,313 +43.9%
Operating profit (loss) 9901 -€36,139 €55,410 +€91,550
Financial income 75/76B €54 €0 -€54 -99.7%
Recurring financial income 75 €54 €0 -€54 -99.7%
Financial charges 65/66B €29,809 €28,938 -€870 -2.9%
Recurring financial charges 65 €29,809 €28,938 -€870 -2.9%
Profit (loss) for the period before taxes 9903 -€65,894 €26,472 +€92,366
Profit (loss) for the period 9904 -€65,894 €26,472 +€92,366
Profit (loss) for the period to be appropriated 9905 -€65,894 €26,472 +€92,366

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.